The fact that the genome-wide score with the known regions removed also showed strong association with type 2 diabetes shows that these associations do not solely reflect the effect of variants within FTO and other BMI genes known to be reliably associated with type 2 diabetes. This evidence concerns the gene FTO and type 2 diabetes mellitus.